Effect of lipo-prostaglandin E₁ on mesangial proliferative glomerulonephritis in rats

Abstract

The antinephritic effect of lipo-prostaglandin E₁, prostaglandin E₁ incorporated in lipid microspheres was investigated using an experimental model of mesangial proliferative glomerulonephritis (MsPGN). Twenty-two female rats were randomly divided into nephritic group (N,n=6), lipo-prostaglandin E₁ treated group (NL,n=8) and control group (C,n=6). Lipo-prostaglandin E₁ was given intravenously at 40 μg·kg⁻¹·d⁻¹ from the 6th week to the 8th week. Twenty-four h urinary protein contents and blood creatinine (Cr) were determined and the pathological changes were observed in the experiment. The expression of proliferating cell nuclear antigen (PCNA), extracellular matrix (fibronectin, FN; collagen type IV, Col IV) and transforming growth factorβ₁ (TGFβ₁) was detected by using immunohistochemistry. The results showed that lipo-prostaglandin E₁ significantly inhibited the glomerular histopathological changes as well as the elevation of plasma Cr (P<0.05). The overexpression of PCNA, FN, Col IV and TGFβ₁ were also obviously inhibited in group NL as compared with the group N (P<0.01). It was suggested that lipo-prostaglandin E₁ could improve renal function, inhibit the proliferation of glomerular cells and reduce the deposition of extracellular matrix, which may be related to the down-regulation of the TGFβ₁ expression.

Keywords

prostaglandins E₁ / nephritis / extracellular matrix

References

[1] SchneiderA, ThaissF, RauH P, et al. . Prostaglandin E₁ inhibits collagen expression in anti-thymocyte antibody-induced glomerulonephritis: possible role of TGFβ₁. Kidney Int, 1996, 50(1): 1990-1990

[2] LiuZ, ZhouS L, TanJ S, et al. . Improving the model of mesangial proliferative glomerulonephritis in rats. J Huaxi Med Univ (Chinese), 1996, 27(2): 182-182

[3] Conde RedondoC, Herreros RodriguezV, Rodriguez-TovesL A, et al. . Glomerular morphologic protection after acute ischemia through the administration of Surgiran: (PGE1 and Alfadex, glucose cyclic oligomer). Arch Esp Urol, 2002, 55(3): 241-241

[4] BorderW A, NobleN A. TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int, 1997, 51(5): 1388-1388

[5] DellK, BohlerT, GaedekeJ, et al. . Prostaglandin E (1) inhibits cyclosporine A-induced upregulation of transforming growth factor-beta 1 in rat mesangial cells. Transplant Proc, 2001, 33(7–8): 3342-3342

[6] OhiraH, SuzukiT, ShishidoS, et al. . Lipo prostaglandin E1 reduces the production of CXC chemokines in endotoxin-induced rat liver injury. Hepatol Res, 2001, 19(1): 74-74